Impact of blaNDM-1 on fitness and pathogenicity of Escherichia coli and Klebsiella pneumoniae

International Journal of Antimicrobial Agents

Volumn 47, Issue 6, 2016, Pages 430-435

  Göttig, Stephan ^a   Riedel Christ, Sara ^a   Saleh, Ahmad ^b   Kempf, Volkhard A J ^a   Hamprecht, Axel ^b,c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Carbapenemase; Enterobacteriaceae; Galleria mellonella; Growth kinetics; New Delhi metallo lactamase; Virulence

Indexed keywords

BETA LACTAMASE; BETA-LACTAMASE NDM-1;

ANIMAL; DISEASE MODEL; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GROWTH, DEVELOPMENT AND AGING; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; LARVA; LEPIDOPTERA; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; PLASMID; SURVIVAL ANALYSIS;

ANIMALS; BETA-LACTAMASES; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LARVA; LEPIDOPTERA; PLASMIDS; SURVIVAL ANALYSIS;

EID: 84969916615     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2016.02.019     Document Type: Article

References (22)

1. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India Antimicrob Agents Chemother 53 2009 5046 5054
2. A. Hamprecht, and S. Göttig Treatment of infections caused by carbapenem-resistant Enterobacteriaceae Curr Treat Options Infect Dis 6 2014 425 438
3. P. Nordmann, L. Poirel, T.R. Walsh, and D.M. Livermore The emerging NDM carbapenemases Trends Microbiol 19 2011 588 595
4. T.R. Walsh, J. Weeks, D.M. Livermore, and M.A. Toleman Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study Lancet Infect Dis 11 2011 355 362
5. S. Göttig, Y. Pfeifer, T.A. Wichelhaus, K. Zacharowski, T. Bingold, B. Averhoff, and et al. Global spread of New Delhi metallo-β-lactamase 1 Lancet Infect Dis 10 2010 828 829
6. NDM-1 J Antimicrob Chemother 70 2015 1026 1030
7. NDM-1-positive Enterobacteriaceae Antimicrob Agents Chemother 55 2011 5403 5407
8. S. Göttig, A.G. Hamprecht, S. Christ, V.A. Kempf, and T.A. Wichelhaus Detection of NDM-7 in Germany, a new variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity J Antimicrob Chemother 68 2013 1737 1740
9. K. Fuursted, L. Scholer, F. Hansen, K. Dam, M.S. Bojer, A.M. Hammerum, and et al. Virulence of a Klebsiella pneumoniae strain carrying the New Delhi metallo-β-lactamase-1 (NDM-1) Microbes Infect 14 2012 155 158
10. T. Yamamoto, T. Takano, Y. Iwao, and A. Hishinuma Emergence of NDM-1-positive capsulated Escherichia coli with high resistance to serum killing in Japan J Infect Chemother 17 2011 435 439
11. S. Göttig, T.M. Gruber, B. Stecher, T.A. Wichelhaus, and V.A. Kempf In vivo horizontal gene transfer of the carbapenemase OXA-48 during a nosocomial outbreak Clin Infect Dis 60 2015 1808 1815
12. R.E. Lenski, S.C. Simpson, and T.T. Nguyen Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness J Bacteriol 176 1994 3140 3147
13. A. Petersen, F.M. Aarestrup, and J.E. Olsen The in vitro fitness cost of antimicrobial resistance in Escherichia coli varies with the growth conditions FEMS Microbiol Lett 299 2009 53 59
14. A. Marra, L. Lamb, I. Medina, D. George, G. Gibson, J. Hardink, and et al. Effect of linezolid on the 50% lethal dose and 50% protective dose in treatment of infections by Gram-negative pathogens in naive and immunosuppressed mice and on the efficacy of ciprofloxacin in an acute murine model of septicemia Antimicrob Agents Chemother 56 2012 4671 4675
15. M. Hornsey, and D.W. Wareham In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection Antimicrob Agents Chemother 55 2011 3534 3537
16. J.L. Insua, E. Llobet, D. Moranta, C. Pérez-Gutiérrez, A. Tomás, J. Garmendia, and et al. Modeling Klebsiella pneumoniae pathogenesis by infection of the wax moth Galleria mellonella Infect Immun 81 2013 3552 3565
17. J.N. Coetzee, N. Datta, and R.W. Hedges R factors from Proteus rettgeri J Gen Microbiol 72 1972 543 552
18. L.S. Munoz-Price, L. Poirel, R.A. Bonomo, M.J. Schwaber, G.L. Daikos, M. Cormican, and et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases Lancet Infect Dis 13 2013 785 796
19. M. Tumbarello, P. Viale, C. Viscoli, E.M. Trecarichi, F. Tumietto, A. Marchese, and et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy Clin Infect Dis 55 2012 943 950
20. S. Datta, S. Roy, S. Chatterjee, A. Saha, B. Sen, T. Pal, and et al. A five-year experience of carbapenem resistance in Enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1 PLoS ONE 9 2014 e112101
21. S.H. MacVane, J.L. Crandon, W.W. Nichols, and D.P. Nicolau Unexpected in vivo activity of ceftazidime alone and in combination with avibactam against New Delhi metallo-β-lactamase-producing Enterobacteriaceae in a murine thigh infection model Antimicrob Agents Chemother 58 2014 7007 7009
22. D.E. Wiskirchen, P. Nordmann, J.L. Crandon, and D.P. Nicolau Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing Enterobacteriaceae in a murine infection model Antimicrob Agents Chemother 57 2013 3936 3940